|
TORONTO, ONTARIO--(Marketwired - Feb. 21, 2017) - Arch Biopartners Inc., (Arch or the Company) (TSX VENTURE:ACH)(OTCBB:FOIFF) a portfolio based biotechnology company, intends to complete a non-brokered private placement offering of up to 1,000,000 common shares priced at $0.40 per common share (the "Common Shares") for gross proceeds of up to $400,000 (the "Offering"). All Common Shares issued in connection with the Offering will be subject to a hold period of four months and one day from the closing date. |
